Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

FOUZEE SugarLin Herbal Formula Recalled for Undeclared Drug Ingredients

Agency Publication Date: January 22, 2025
Share:
Sign in to monitor this recall

Summary

Shoppers-Plaza is recalling 172 bottles of FOUZEE SugarLin Herbal Formula (180-count capsules) because FDA laboratory testing confirmed the product is tainted with metformin and glyburide. These are prescription drugs used to treat type 2 diabetes and were not listed on the product's label. This product is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

Risk

The undeclared metformin and glyburide can cause blood sugar levels to drop dangerously low, a condition called hypoglycemia. This poses a significant health risk, especially for individuals already taking medication for diabetes, as the hidden ingredients could lead to a life-threatening drug interaction or accidental overdose.

What You Should Do

  1. This recall affects 180-count bottles of FOUZEE SugarLin HERBAL FORMULA capsules with UPC 826656690477, Batch # 001, and an expiration date of 09/10/2026.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for additional questions or to report adverse effects.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: FOUZEE SugarLin HERBAL FORMULA capsules (180 capsules)
Variants: 180 capsules
UPC Codes:
826656690477
Lot Numbers:
001 (Exp 09/10/2026)

Product of India; Batch # 001

Product Images

“Product label Fouzee SugarLin Herbal Formula Herbal Dietary Supplement 180 Veg Capsules”

“Product label Fouzee SugarLin Herbal Formula Herbal Dietary Supplement 180 Veg Capsules”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 95994
Status: Active
Manufacturer: SHOPPERS- PLAZA
Sold By: internet sales
Manufactured In: India, United States
Units Affected: 172 180-count bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.